Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs GSK✓SelectedUSD · GSKSAP vs GSK performance historyLatest closeAs of-0.46%11/16
Stock and ETF performance explorer

SAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+78.8%
GSK return
+46.9%
Excess return
+31.9%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%-0.1%-0.4%-0.4%
7D-1.5%-1.3%-0.2%-1.2%
30D+4.3%+2.7%+1.5%+3.6%
3M+12.4%+2.7%+9.7%+11.6%
6M+38.0%+3.3%+34.6%+36.7%
YTD-2.1%+6.5%-8.5%-4.5%
1Y-2.9%+10.7%-13.6%-6.3%
3Y+63.6%+64.4%-0.8%+38.4%
5Y+78.8%+46.7%+32.1%+41.1%
All+78.8%+46.9%+31.9%+41.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling